Share：
Share this content in WeChat
X
[Chinese][PDF]90199
• Review •
Advances in multimodal MRI of cognitive impairment in neuromyelitis optica
YANG Yang  LI Yonggang 

Cite this article as: Yang Y, Li YG. Advances in multimodal MRI of cognitive impairment in neuromyelitis optica. Chin J Magn Reson Imaging, 2020, 11(8): 688-690. DOI:10.12015/issn.1674-8034.2020.08.023.


[Abstract] Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of central nervous system (CNS) whose main characteristic is the compromise of the spinal cord and the optic nerves. Moreover, it can also affect the brain, leading to cognitive impairment. In recent years, many scholars have carried out clinical and neuroimaging studies on cognitive impairment of neuromyelitis optica. And multimodal MRI plays an important role in explaining the possible mechanism behind it. The purpose of this article is to review the recent MRI findings in cognitive impairment in NMO.
[Keywords] neuromyelitis optica；cognitive impairment；magnetic resonance imaging

YANG Yang Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215000, China

LI Yonggang* Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215000, China

*Corresponding to: Li YG, E-mail: liyonggang224@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of National Natural Science Foundation of China No.81671743 Clinical Key Diseases Diagnosis and Therapy Special Foundation of Suzhou City No.LCZX201801
Received  2020-03-18
Accepted  2020-04-12
DOI: 10.12015/issn.1674-8034.2020.08.023
Cite this article as: Yang Y, Li YG. Advances in multimodal MRI of cognitive impairment in neuromyelitis optica. Chin J Magn Reson Imaging, 2020, 11(8): 688-690. DOI:10.12015/issn.1674-8034.2020.08.023.

[1]
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet, 2004, 364(9451): 2106-2112.
[2]
Hubbard JA, Szu JI, Binder DK. The role of aquaporin-4 in synaptic plasticity, memory and disease. Brain Res Bull, 2018, 136(1): 118-129.
[3]
Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology, 2015, 85(2): 177-189.
[4]
Moore P, Methley A, Pollard C, et al. Cognitive and psychiatric comorbidities in neuromyelitis optica. J Neurol Sci, 2016, 360(1): 4-9.
[5]
Meng H, Xu J, Pan C, et al. Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis. J Neurol, 2017, 264(8): 1549-1558.
[6]
Vanotti S, Cores EV, Eizaguirre B, et al. Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis. Arq Neuropsiquiatr, 2013, 71(6): 357-361.
[7]
Kim SH, Kwak K, Jeong IH, et al. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler, 2016, 22(14): 1850-1858.
[8]
Blanc F, Zephir H, Lebrun C, et al. Cognitive functions in neuromyelitis optica. Arch Neurol, 2008, 65(1): 84-88.
[9]
Saji E, Arakawa M, Yanagawa K, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol, 2013, 73(1): 65-76.
[10]
Liu Y, Fu Y, Schoonheim MM, et al. Structural MRI substrates of cognitive impairment in neuromyelitis optica. Neurology, 2015, 85(17): 1491-1499.
[11]
Chen X, Fu J, Luo Q, et al. Altered volume and microstructural integrity of hippocampus in NMOSD. Mult Scler Relat Disord, 2019, 28(2): 132-137.
[12]
Liu Y, Jiang X, Butzkueven H, et al. Multimodal characterization of gray matter alterations in neuromyelitis optica. Mult Scler, 2018, 24(10): 1308-1316.
[13]
Kim SH, Park EY, Park B, et al. Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder. Sci Rep, 2017, 7(1): 9180.
[14]
Masuda H, Hirano S, Takahashi N, et al. Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PLoS One, 2017, 12(8): e0184012.
[15]
Cho EB, Han CE, Seo SW, et al. White matter network disruption and cognitive dysfunction in neuromyelitis optica spectrum disorder. Front Neurol, 2018, 9(12): 1104.
[16]
Lu P, Yuan T, Liu X, et al. Role of diffusional kurtosis imaging in differentiating neuromyelitis optica-related and multiple sclerosis-related acute optic neuritis: Comparison with diffusion-weighted imaging. J Comput Assist Tomogr, 2020, 44(1): 47-52.
[17]
Han Y, Liu Y, Zeng C, et al. Functional connectivity alterations in neuromyelitis optica spectrum disorder: Correlation with disease duration and cognitive impairment. Clin Neuroradiol, 2019, 29(4): 1-10.
[18]
Savoldi F, Rocca MA, Valsasina P, et al. Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder. Mult Scler, 2019, 25(6): 1-11.
[19]
Guo X, Zhu J, Zhang N, et al. Altered neurovascular coupling in neuromyelitis optica. Hum Brain Mapp, 2019, 40(3): 976-986.
[20]
Wang F, Liu Y, Li J, et al. Abnormal brain function in neuromyelitis optica: A fMRI investigation of mPASAT. Eur J Radiol, 2017, 95(10): 197-201.
[21]
Wang J, Tian Y, Shao Y, et al. Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study. Neuropsychiatr Dis Treat, 2017, 13(10): 2669-2679.
[22]
Cai H, Zhu J, Zhang N, et al. Subregional structural and connectivity damage in the visual cortex in neuromyelitis optica. Sci Rep, 2017, 7(2): 41914.
[23]
De Seze J, Blanc F, Kremer S, et al. Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica. J Neurol Neurosurg Psychiatry, 2010, 81(4): 409-411.
[24]
Aboul-Enein F, Krssak M, Hoftberger R, et al. Diffuse white matter damage is absent in neuromyelitis optica. AJNR Am J Neuroradiol, 2010, 31(1): 76-79.
[25]
Duan Y, Liu Z, Liu Y, et al. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study. Acta Radiol, 2017, 58(9): 1132-1137.
[26]
Pichiecchio A, Tavazzi E, Poloni G, et al. Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler, 2012, 18(6): 817-824.
[27]
Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain, 2005, 128(Pt 11): 2705-2712.
[28]
Chou IJ, Tanasescu R, Mougin OE, et al. Reduced myelin signal in normal-appearing white matter in neuromyelitis optica measured by 7T magnetic resonance imaging. Sci Rep, 2019, 9(1): 14378.
[29]
Blanc F, Noblet V, Jung B, et al. White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS One, 2012, 7(4): e33878.
[30]
Wang Q, Zhang N, Qin W, et al. Gray matter volume reduction is associated with cognitive impairment in neuromyelitis optica. AJNR Am J Neuroradiol, 2015, 36(10): 1822-1829.
[31]
Hyun JW, Park G, Kwak K, et al. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis. Eur J Neurol, 2017, 24(2): 437-445.
[32]
Minagar A, Barnett MH, Benedict RH, et al. The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology, 2013, 80(2): 210-219.
[33]
Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol, 2006, 63(7): 964-968.
[34]
Kremer S, Renard F, Noblet V, et al. Diffusion tensor imaging in human global cerebral anoxia: correlation with histology in a case with autopsy. J Neuroradiol, 2010, 37(5): 301-303.
[35]
Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci, 2007, 8(9): 700-711.
[36]
韩永良，李咏梅，罗琦，等．视神经脊髓炎患者功能连接密度变化的静息态fMRI研究．磁共振成像, 2018, 9(1): 33-37
[37]
韩永良，李咏梅，罗琦，等．视神经脊髓炎患者默认网络及额顶网络功能连接的研究．磁共振成像, 2017, 8(2): 105-109.
[38]
Zang Y, Jiang T, Lu Y, et al. Regional homogeneity approach to fMRI data analysis. Neuroimage, 2004, 22(1): 394-400.
[39]
Schmierer K, Scaravilli F, Altmann DR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol, 2004, 56(3): 407-415.

PREV Research progress on the regulation target of real-time functional magnetic resonance imaging neurofeedback
NEXT Advances of fMRI in preoperative localization and prognosis evaluation of temporal lobe epilepsy
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn